Concepedia

Bingjun Sun

BS

67

Publications

4.3K

Citations

34

H-Index

2016

Active since

Affiliations

Shenyang Pharmaceutical University(Current)

China Medical University

Liaoning Cancer Hospital & Institute

Jinzhou Medical University

University of North Carolina at Chapel Hill

Bingjun Sun is an author at Shenyang Pharmaceutical University specializing in nanomedicine, engineering, and medicine.

ORCID

Top concepts

Publications per year

2016–2024

67

Publications

67

Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy

Cong Luo, Jin Sun, Dan Liŭ et al. · Nano Letters · 2016 · 431 citations · Full text

, , +15

Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy

Bingjun Sun, Cong Luo, Yu Han et al. · Nano Letters · 2018 · 399 citations

Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy

Bingjun Sun, Cong Luo, Xuanbo Zhang et al. · Nature Communications · 2019 · 314 citations · Full text

Trisulfide bond–mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity

Yinxian Yang, Bingjun Sun, Shiyi Zuo et al. · Science Advances · 2020 · 278 citations · Full text

Facile Fabrication of Tumor Redox‐Sensitive Nanoassemblies of Small‐Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine

Cong Luo, Jin Sun, Bingjun Sun et al. · Small · 2016 · 171 citations · Full text

, , +19

Rows per page

1–5 of 67